Cargando…
The safety of remifentanil administered for up to 5 days in ICU patients with neurotrauma
Autores principales: | Stergiopoulos, S, Karabinis, A, Mandragos, K, Komnos, A, Soukup, J, Speelberg, B, Kirkham, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099822/ http://dx.doi.org/10.1186/cc2702 |
Ejemplares similares
-
Remifentanil-based analgesia and sedation facilitates more rapid and predictable time to neurological assessments
por: Karabinis, A, et al.
Publicado: (2004) -
Safety and efficacy of analgesia-based sedation with remifentanil versus standard hypnotic-based regimens in intensive care unit patients with brain injuries: a randomised, controlled trial [ISRCTN50308308]
por: Karabinis, Andreas, et al.
Publicado: (2004) -
Remifentanil-based analgesia and sedation is well tolerated when administered for up to 10 days in mechanically ventilated ICU patients
por: Karabinis, A, et al.
Publicado: (2004) -
Remifentanil in neurosurgical patients in the intensive care unit
por: Koukoulitsios, G, et al.
Publicado: (2005) -
Remifentanil target-controlled infusion for fiberoptic bronchoscopy in the ICU: feasability, safety and tolerance evaluation
por: Caron, M, et al.
Publicado: (2015)